Effect of Auryxia on ESA Utilization in ESRD Patients With High Ferritin & Low Transferrin Saturation: A Pilot Project
Status: Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 22 Apr 2019
Price : $35 *
At a glance
- Drugs Ferric citrate (Primary)
- Indications Iron deficiency anaemia
- Focus Therapeutic Use
- 15 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 07 Mar 2019 Planned primary completion date changed from 1 Feb 2019 to 30 Sep 2019.
- 31 Aug 2018 Biomarkers information updated